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Background:  Evaluation of right (RV) and left ventricular (LV) function provides prognostic and diagnostic information for coronary heart disease. 
The current study compares agreement of the Simpson’s method versus timing bolus method to assess RV and LV function through computed 
tomography angiography (CTA).
Methods:  Eighty three subjects (age 63±10, 34% female) underwent CTA. RV and LV ejection fraction (EF) were measured using Simpson’s 
method and timing bolus method. Based on Dye dilution technique, the RV and LV EF were measured during timing bolus contrast injection. RVEF 
was calculated as: (peak hounsfield-unit(HU) in pulmonary artery(PA)/ peak HU in superior vena cava)*(time to peak HU in PA- time to peak HU in 
SVC)/100.LVEF calculated as:(peak HU in ascending aorta(AA)/ peak HU in PA))*(time to peak HU in AA- time to peak HU in PA)/100.
Results:  There was good agreement between Simpson’s method and timing bolus method in RV and LV EF assessment.This agreement remained 
significant among subjects with and without coronary plaque (r=0.93, p=0.0001)(Table). The inter- and intra-observer coefficient of variation for RV 
and LV EF measurement using the timing bolus method was 0.02 and 0.01, respectively. The mean LVEF was 23.5% lower in CAD as compared to 
non-CAD cohort. Similarly, the CAD cohort had 19.8% lower RVEF as compared to non-CAD cohort.
Conclusion: RV and LV EF can be accurately measured using timing bolus method; highlighting its clinical application especially in prospective 
gated CTA. 
